NuGen Announces Voting Results of Annual and Special Meeting
September 22, 2026 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) is pleased to announce voting results from the annual and special meeting of the Company’s shareholders (the “Meeting”) held on September 21, 2026. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set out in the Management Information Circular (the “Management Information Circular”) dated August 17, 2026. The Management Information Circular is available on SEDAR+ (www.sedarplus.ca).
Election of Directors
All of the board of director nominees listed in the Management Information Circular were elected as directors of the Company. Results of the vote were as follows:
| Nominee | Votes For |
| Karen Dunlap | 99.93% |
| John Leombruno | 99.96% |
| Philip Cortese | 60.31% |
| Liang Lin | 99.76% |
| Arvind Rai | 58.62% |
| Louise Cresswell | 58.80% |
| Kwun Loy Liu | 98.27% |
Other Items of Business
In addition, at the Meeting, shareholders approved the appointment of the Company’s auditors, KPMG LLP, and the annual approval and confirmation of the company’s stock option plan. The results of the votes were as follows:
| Item | Votes For |
| Appointment of KPMG LLP as auditors of the Company | 99.97% |
| Approval of Stock Option Plan | 59.76% |
About NuGen Medical Devices
NuGen develops needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide.
For further information, please visit:
Websites: insujet.com | insujet.fr | nugenmd.com
LinkedIn: https://www.linkedin.com/company/nugenmd/
Investor relations: IR@nugenmd.com
For further information, please contact:
Ajay Mishra
Chief Financial Officer
+1-833-867-5557
ir@nugenmd.com
Notice Regarding Forward-Looking Information:
Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.